Photo Courtesy Merck & Co Inc/Handout via REUTERS
The Food and Drug Administration (FDA) on Thursday authorized the use of Merck and Ridgeback Biotherapeutics’ molnupiravir pill for treating COVID-19, the second such emergency use authorization in two days.
Read the full story at Fox Business | News.